Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2022
2021
2020
Profitability Metrics
Gross Margin
100.00%
Operating Margin
83.69%
Net Margin
102.83%
Efficiency Metrics
Revenue per Expense Ratio
6.13
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
0.8700000000
Balance Sheet Analysis
Current Ratio
2.89
Cash Ratio
2.72
Working Capital
$8.34M
Debt to Equity
0.01
Debt to Assets
0.37%
Equity Ratio
60.18%
Cash Flow Analysis
Operating Cash Flow Ratio
17.39%
Free Cash Flow Ratio
17.39%
CapEx to Revenue
0.00%
Dividends Paid
$13.35M
Stock Buybacks
$1.86M
Total Shareholder Returns
$15.20M
Cash Position Change
-26.61%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
149.52%
Net Income
150.64%
EPS
150.58%
Operating Income
4.01%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
4.99%
Operating Cash Flow
-78.62%
Free Cash Flow
-78.62%
Balance Sheet Health
Assets
2.95%
Debt
-99.04%
Book Value per Share
3.98%
Inventory
100.00%
Shareholder Returns
Dividends per Share
-30.95%
Shares Outstanding
-0.44%
Long Term Trends
3Y Revenue/Share
2,278.66%
5Y Revenue/Share
-6.66%
3Y Dividend/Share
-44.00%
5Y Dividend/Share
-44.54%